Header cover image

Australian Pharmaceuticals & Biotech Buy the Dip

UPDATED Aug 16, 2022

Companies which may present a buying opportunity after a dip in share price.

6 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CUVClinuvel PharmaceuticalsAU$20.05-0.05%-28.0%AU$990.7mAU$26.31PE41.1xE30.6%0.1%
IMMImmutepAU$0.33-3.0%-28.6%AU$281.5mAU$1.22PS75.6xE62.9%n/a
TRJTrajan Group HoldingsAU$2.215.7%-28.9%AU$336.0mAU$3.22PS4.1xE80.9%n/a
KZAKazia TherapeuticsAU$0.250%-80.2%AU$37.4mn/aPS2.5xE51.5%n/a
AVHAVITA MedicalAU$1.98-10.2%-58.0%AU$246.9mAU$3.34PS7xE25.9%n/a
CAUCronos AustraliaAU$0.3117.0%158.3%AU$171.3mn/aPS7.9xn/an/a
Page 1 of 1